The present disclosure relates to a culturing patch, culturing method, culture test method, culture test device, drug test method, and drug test device, and the culturing patch according to an aspect of the present disclosure includes component required for growth of an object to be cultured, and a mesh structural body provided in a mesh structure forming micro-cavities in which the component required for growth are contained that is configured to come into contact with a reaction region in which the object to be cultured is placed and provide some of the contained component required for growth to the reaction region.
Legal claims defining the scope of protection, as filed with the USPTO.
1. A drug patch comprising: a drug that affects growth or activity of an object to be drug-tested; and a mesh structural body provided in a mesh structure forming micro-cavities in which the drug is contained that is configured to come into contact with a reaction region comprising the object to be drug-tested and to provide the contained drug from the micro-cavities to the reaction region, wherein the mesh structural body is a continuously distributed solid structure having a plurality of micro-threads that are intertwined together.
2. The drug patch of claim 1 , further comprising a component required for growth of the object to be drug-tested, wherein the component required for growth is contained in the mesh structure forming the micro-cavities.
3. The drug patch of claim 1 , wherein the mesh structural body further comprises a nutrient component for growth of the object.
4. The drug patch of claim 3 , wherein the nutrient component comprises at least one of bacteria or cells.
5. The drug patch of claim 1 , wherein the object comprises at least one of bacteria, parasites, cells separated from a tissue, or primary cultured cells.
6. The drug patch of claim 1 , wherein a liquid substance is contained within the micro-cavities.
7. The drug patch of claim 1 , wherein the reaction region comprises at least one of another patch, a dried region, or a liquid region.
8. A drug patch comprising: a drug that affects growth or activity of an object to be drug-tested; a mesh structural body comprising micro-cavities containing antibodies, wherein the mesh structural body is configured to come into contact with a reaction region comprising the drug and to provide the drug to the reaction region, wherein the mesh structural body is a continuously distributed solid structure having a plurality of micro-threads that are intertwined together; and a water film between the mesh structural body and the reaction region, wherein the drug is provided to the reaction region through the water film.
9. The drug patch of claim 8 , further comprising a component required for growth of the object to be drug-tested, wherein the component required for growth is contained in the mesh structure forming the micro-cavities.
10. The drug patch of claim 8 , wherein the mesh structural body further comprises a nutrient component for growth of the object.
11. The drug patch of claim 10 , wherein the nutrient component comprises at least one of bacteria or cells.
12. The drug patch of claim 8 , wherein the object comprises at least one of bacteria, parasites, cells separated from a tissue, or primary cultured cells.
13. The drug patch of claim 8 , wherein a liquid substance is contained within the micro-cavities.
14. The drug patch of claim 8 , wherein the reaction region comprises at least one of another patch, a dried region, or a liquid region.
15. A drug patch comprising: a drug that affects growth or activity of an object to be drug-tested; a buffer solution for facilitating an environmental condition for growth of the object; and a mesh structural body comprising micro-cavities containing antibodies and an interruption solution, wherein the mesh structural body is configured to come into contact with an external reaction region and to provide the drug to the external reaction region, wherein the mesh structural body is a continuously distributed solid structure having a plurality of micro-threads that are intertwined together.
16. The drug patch of claim 15 , wherein the buffer solution adjusts at least one of an acidity or an osmotic pressure.
17. The drug patch of claim 15 , wherein the mesh structural body further comprises a nutrient component for growth of the object, the nutrient component comprising at least one of bacteria or cells.
18. The drug patch of claim 15 , wherein the object comprises at least one of bacteria, parasites, cells separated from a tissue, or primary cultured cells.
19. The drug patch of claim 15 , wherein a liquid substance is contained within the micro-cavities.
20. The drug patch of claim 1 , wherein an external substance comprising the drug is absorbed from external region prior to being provided to the reaction region.
21. The drug patch of claim 1 , wherein the drug is absorbed from an external substance prior to being provided to the reaction region, wherein the external substance comprises at least one of a liquid comprising the drug or a powder comprising the drug.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
February 23, 2017
June 22, 2021
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.